Brian Fife

Brian Fife, PhD, serves as Professor of Medicine and Director of the Center for Autoimmune Disease Research, dedicating his career to unraveling the immunological mechanisms underlying autoimmune disorders with primary emphasis on type 1 diabetes pathogenesis and intervention strategies.

His research program centers on T cell biology and immune regulation, specifically investigating T cell migration dynamics, tolerance mechanisms, and the critical roles of inhibitory receptors like PD-1 in autoimmune contexts. This work spans autoimmune disease research, transplantation immunology for islet replacement therapies, and cancer immunology applications in melanoma and pancreatic tumor models, revealing fundamental insights into immune cell behavior across disease states.

Analysis of Dr. Fife's 15 most recent publications (2020-2025) demonstrates pioneering contributions to CAR Treg therapy development for autoimmune diabetes prevention and islet transplantation tolerance, alongside innovative work characterizing T cell migration in tumor microenvironments and defining hybrid insulin peptide-specific T cell responses in diabetes initiation. His research consistently bridges molecular mechanisms with translational applications.

As Director of the Center for Autoimmune Disease Research, Dr. Fife leads a multidisciplinary team employing advanced methodologies including intravital imaging, T cell receptor engineering, and sophisticated mouse models to develop novel immunotherapeutic approaches for autoimmune conditions, with particular focus on antigen-specific interventions that preserve immune competence while halting disease progression.